1. Home
  2. SRDX vs CADL Comparison

SRDX vs CADL Comparison

Compare SRDX & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • CADL
  • Stock Information
  • Founded
  • SRDX 1979
  • CADL 1999
  • Country
  • SRDX United States
  • CADL United States
  • Employees
  • SRDX N/A
  • CADL N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • CADL Biotechnology: Pharmaceutical Preparations
  • Sector
  • SRDX Health Care
  • CADL Health Care
  • Exchange
  • SRDX Nasdaq
  • CADL Nasdaq
  • Market Cap
  • SRDX 402.2M
  • CADL 339.8M
  • IPO Year
  • SRDX 1998
  • CADL 2021
  • Fundamental
  • Price
  • SRDX $41.40
  • CADL $4.90
  • Analyst Decision
  • SRDX Buy
  • CADL Strong Buy
  • Analyst Count
  • SRDX 3
  • CADL 7
  • Target Price
  • SRDX $43.00
  • CADL $19.57
  • AVG Volume (30 Days)
  • SRDX 252.6K
  • CADL 630.6K
  • Earning Date
  • SRDX 11-05-2025
  • CADL 11-14-2025
  • Dividend Yield
  • SRDX N/A
  • CADL N/A
  • EPS Growth
  • SRDX N/A
  • CADL N/A
  • EPS
  • SRDX N/A
  • CADL N/A
  • Revenue
  • SRDX $120,801,000.00
  • CADL N/A
  • Revenue This Year
  • SRDX N/A
  • CADL N/A
  • Revenue Next Year
  • SRDX $3.38
  • CADL N/A
  • P/E Ratio
  • SRDX N/A
  • CADL N/A
  • Revenue Growth
  • SRDX N/A
  • CADL N/A
  • 52 Week Low
  • SRDX $25.87
  • CADL $3.79
  • 52 Week High
  • SRDX $41.67
  • CADL $14.60
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 83.94
  • CADL 39.05
  • Support Level
  • SRDX $26.00
  • CADL $4.77
  • Resistance Level
  • SRDX $28.67
  • CADL $5.32
  • Average True Range (ATR)
  • SRDX 0.94
  • CADL 0.26
  • MACD
  • SRDX 1.54
  • CADL -0.05
  • Stochastic Oscillator
  • SRDX 98.23
  • CADL 12.72

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: